nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ACE—chronic obstructive pulmonary disease	0.767	1	CbGaD
Cilazapril—ACE—pulmonary artery—chronic obstructive pulmonary disease	0.00837	0.47	CbGeAlD
Cilazapril—ACE—respiratory system—chronic obstructive pulmonary disease	0.00141	0.079	CbGeAlD
Cilazapril—ACE—connective tissue—chronic obstructive pulmonary disease	0.00124	0.0695	CbGeAlD
Cilazapril—SLC15A2—respiratory system—chronic obstructive pulmonary disease	0.00123	0.0689	CbGeAlD
Cilazapril—ACE—smooth muscle tissue—chronic obstructive pulmonary disease	0.00113	0.0636	CbGeAlD
Cilazapril—Fosinopril—ACE—chronic obstructive pulmonary disease	0.00107	0.133	CrCbGaD
Cilazapril—SLC15A2—bronchus—chronic obstructive pulmonary disease	0.00101	0.0567	CbGeAlD
Cilazapril—SLC15A2—trachea—chronic obstructive pulmonary disease	0.000908	0.0509	CbGeAlD
Cilazapril—Perindopril—ACE—chronic obstructive pulmonary disease	0.000874	0.108	CrCbGaD
Cilazapril—Spirapril—ACE—chronic obstructive pulmonary disease	0.000864	0.107	CrCbGaD
Cilazapril—Moexipril—ACE—chronic obstructive pulmonary disease	0.000828	0.103	CrCbGaD
Cilazapril—Quinapril—ACE—chronic obstructive pulmonary disease	0.00077	0.0955	CrCbGaD
Cilazapril—Lisinopril—ACE—chronic obstructive pulmonary disease	0.00077	0.0955	CrCbGaD
Cilazapril—ACE—lung—chronic obstructive pulmonary disease	0.000748	0.0419	CbGeAlD
Cilazapril—Ramipril—ACE—chronic obstructive pulmonary disease	0.000746	0.0925	CrCbGaD
Cilazapril—Trandolapril—ACE—chronic obstructive pulmonary disease	0.000746	0.0925	CrCbGaD
Cilazapril—Benazepril—ACE—chronic obstructive pulmonary disease	0.00067	0.0831	CrCbGaD
Cilazapril—SLC15A2—lung—chronic obstructive pulmonary disease	0.000652	0.0366	CbGeAlD
Cilazapril—Enalapril—ACE—chronic obstructive pulmonary disease	0.000565	0.0701	CrCbGaD
Cilazapril—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000496	0.0278	CbGeAlD
Cilazapril—ABCB1—trachea—chronic obstructive pulmonary disease	0.000366	0.0206	CbGeAlD
Cilazapril—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000359	0.00173	CcSEcCtD
Cilazapril—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000359	0.00173	CcSEcCtD
Cilazapril—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000359	0.00173	CcSEcCtD
Cilazapril—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.00173	CcSEcCtD
Cilazapril—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.00173	CcSEcCtD
Cilazapril—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.00172	CcSEcCtD
Cilazapril—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000358	0.00172	CcSEcCtD
Cilazapril—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000357	0.00172	CcSEcCtD
Cilazapril—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000357	0.00172	CcSEcCtD
Cilazapril—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000357	0.00172	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000356	0.00172	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000356	0.00172	CcSEcCtD
Cilazapril—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000354	0.00171	CcSEcCtD
Cilazapril—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000354	0.00171	CcSEcCtD
Cilazapril—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.00169	CcSEcCtD
Cilazapril—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000351	0.00169	CcSEcCtD
Cilazapril—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000351	0.00169	CcSEcCtD
Cilazapril—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000351	0.00169	CcSEcCtD
Cilazapril—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000351	0.00169	CcSEcCtD
Cilazapril—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00035	0.00169	CcSEcCtD
Cilazapril—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.00169	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000349	0.00168	CcSEcCtD
Cilazapril—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000348	0.00168	CcSEcCtD
Cilazapril—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000347	0.00167	CcSEcCtD
Cilazapril—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00166	CcSEcCtD
Cilazapril—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00166	CcSEcCtD
Cilazapril—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000344	0.00166	CcSEcCtD
Cilazapril—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00163	CcSEcCtD
Cilazapril—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00163	CcSEcCtD
Cilazapril—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00163	CcSEcCtD
Cilazapril—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000339	0.00163	CcSEcCtD
Cilazapril—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.00163	CcSEcCtD
Cilazapril—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000337	0.00162	CcSEcCtD
Cilazapril—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00162	CcSEcCtD
Cilazapril—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000336	0.00162	CcSEcCtD
Cilazapril—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.00162	CcSEcCtD
Cilazapril—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000335	0.00161	CcSEcCtD
Cilazapril—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000334	0.00161	CcSEcCtD
Cilazapril—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000334	0.00161	CcSEcCtD
Cilazapril—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000333	0.0016	CcSEcCtD
Cilazapril—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000331	0.0016	CcSEcCtD
Cilazapril—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00033	0.00159	CcSEcCtD
Cilazapril—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000327	0.00158	CcSEcCtD
Cilazapril—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00157	CcSEcCtD
Cilazapril—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.00155	CcSEcCtD
Cilazapril—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000321	0.00155	CcSEcCtD
Cilazapril—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000321	0.00155	CcSEcCtD
Cilazapril—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00032	0.00154	CcSEcCtD
Cilazapril—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000319	0.00154	CcSEcCtD
Cilazapril—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000319	0.00154	CcSEcCtD
Cilazapril—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00153	CcSEcCtD
Cilazapril—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.00152	CcSEcCtD
Cilazapril—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000314	0.00151	CcSEcCtD
Cilazapril—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.00151	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000313	0.00151	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000313	0.00151	CcSEcCtD
Cilazapril—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000311	0.0015	CcSEcCtD
Cilazapril—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.0015	CcSEcCtD
Cilazapril—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.00149	CcSEcCtD
Cilazapril—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000309	0.00149	CcSEcCtD
Cilazapril—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000308	0.00148	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000307	0.00148	CcSEcCtD
Cilazapril—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.00148	CcSEcCtD
Cilazapril—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000307	0.00148	CcSEcCtD
Cilazapril—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00147	CcSEcCtD
Cilazapril—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00147	CcSEcCtD
Cilazapril—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000305	0.00147	CcSEcCtD
Cilazapril—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000304	0.00146	CcSEcCtD
Cilazapril—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.00146	CcSEcCtD
Cilazapril—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000303	0.00146	CcSEcCtD
Cilazapril—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000303	0.00146	CcSEcCtD
Cilazapril—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000302	0.00146	CcSEcCtD
Cilazapril—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000301	0.00145	CcSEcCtD
Cilazapril—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000299	0.00144	CcSEcCtD
Cilazapril—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000299	0.00144	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000297	0.00143	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000297	0.00143	CcSEcCtD
Cilazapril—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000297	0.00143	CcSEcCtD
Cilazapril—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000297	0.00143	CcSEcCtD
Cilazapril—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000297	0.00143	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.00143	CcSEcCtD
Cilazapril—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00142	CcSEcCtD
Cilazapril—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00142	CcSEcCtD
Cilazapril—Pain—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00142	CcSEcCtD
Cilazapril—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00142	CcSEcCtD
Cilazapril—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.00142	CcSEcCtD
Cilazapril—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00141	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000291	0.0014	CcSEcCtD
Cilazapril—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00029	0.0014	CcSEcCtD
Cilazapril—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.0014	CcSEcCtD
Cilazapril—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00139	CcSEcCtD
Cilazapril—Pain—Montelukast—chronic obstructive pulmonary disease	0.000288	0.00139	CcSEcCtD
Cilazapril—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000288	0.00139	CcSEcCtD
Cilazapril—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000287	0.00138	CcSEcCtD
Cilazapril—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000286	0.00138	CcSEcCtD
Cilazapril—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00138	CcSEcCtD
Cilazapril—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000286	0.00138	CcSEcCtD
Cilazapril—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000285	0.00137	CcSEcCtD
Cilazapril—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000285	0.00137	CcSEcCtD
Cilazapril—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000284	0.00137	CcSEcCtD
Cilazapril—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000283	0.00137	CcSEcCtD
Cilazapril—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.00137	CcSEcCtD
Cilazapril—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000283	0.00136	CcSEcCtD
Cilazapril—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00136	CcSEcCtD
Cilazapril—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000282	0.00136	CcSEcCtD
Cilazapril—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000282	0.00136	CcSEcCtD
Cilazapril—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000281	0.00136	CcSEcCtD
Cilazapril—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000281	0.00136	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00135	CcSEcCtD
Cilazapril—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00135	CcSEcCtD
Cilazapril—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00134	CcSEcCtD
Cilazapril—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00134	CcSEcCtD
Cilazapril—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000275	0.00133	CcSEcCtD
Cilazapril—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000275	0.00133	CcSEcCtD
Cilazapril—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000273	0.00132	CcSEcCtD
Cilazapril—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.00132	CcSEcCtD
Cilazapril—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000272	0.00131	CcSEcCtD
Cilazapril—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.00131	CcSEcCtD
Cilazapril—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000271	0.00131	CcSEcCtD
Cilazapril—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000269	0.00129	CcSEcCtD
Cilazapril—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000268	0.00129	CcSEcCtD
Cilazapril—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000268	0.00129	CcSEcCtD
Cilazapril—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000268	0.00129	CcSEcCtD
Cilazapril—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00129	CcSEcCtD
Cilazapril—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000267	0.00129	CcSEcCtD
Cilazapril—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000267	0.00129	CcSEcCtD
Cilazapril—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000266	0.00128	CcSEcCtD
Cilazapril—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000266	0.00128	CcSEcCtD
Cilazapril—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00128	CcSEcCtD
Cilazapril—ABCB1—lung—chronic obstructive pulmonary disease	0.000263	0.0148	CbGeAlD
Cilazapril—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00124	CcSEcCtD
Cilazapril—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.00124	CcSEcCtD
Cilazapril—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00122	CcSEcCtD
Cilazapril—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00122	CcSEcCtD
Cilazapril—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000253	0.00122	CcSEcCtD
Cilazapril—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000253	0.00122	CcSEcCtD
Cilazapril—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000248	0.0012	CcSEcCtD
Cilazapril—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.00119	CcSEcCtD
Cilazapril—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000247	0.00119	CcSEcCtD
Cilazapril—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.00117	CcSEcCtD
Cilazapril—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000243	0.00117	CcSEcCtD
Cilazapril—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00116	CcSEcCtD
Cilazapril—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00115	CcSEcCtD
Cilazapril—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000238	0.00115	CcSEcCtD
Cilazapril—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.00113	CcSEcCtD
Cilazapril—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000235	0.00113	CcSEcCtD
Cilazapril—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.00113	CcSEcCtD
Cilazapril—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000233	0.00112	CcSEcCtD
Cilazapril—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.00112	CcSEcCtD
Cilazapril—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00112	CcSEcCtD
Cilazapril—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00023	0.00111	CcSEcCtD
Cilazapril—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.00111	CcSEcCtD
Cilazapril—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000227	0.0011	CcSEcCtD
Cilazapril—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.0011	CcSEcCtD
Cilazapril—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000223	0.00107	CcSEcCtD
Cilazapril—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000223	0.00107	CcSEcCtD
Cilazapril—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00107	CcSEcCtD
Cilazapril—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000219	0.00106	CcSEcCtD
Cilazapril—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000219	0.00105	CcSEcCtD
Cilazapril—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.00105	CcSEcCtD
Cilazapril—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.00105	CcSEcCtD
Cilazapril—Rash—Formoterol—chronic obstructive pulmonary disease	0.000217	0.00105	CcSEcCtD
Cilazapril—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.00104	CcSEcCtD
Cilazapril—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000217	0.00104	CcSEcCtD
Cilazapril—Headache—Formoterol—chronic obstructive pulmonary disease	0.000215	0.00104	CcSEcCtD
Cilazapril—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000215	0.00104	CcSEcCtD
Cilazapril—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.00103	CcSEcCtD
Cilazapril—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000215	0.00103	CcSEcCtD
Cilazapril—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000214	0.00103	CcSEcCtD
Cilazapril—Rash—Montelukast—chronic obstructive pulmonary disease	0.000212	0.00102	CcSEcCtD
Cilazapril—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000212	0.00102	CcSEcCtD
Cilazapril—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000212	0.00102	CcSEcCtD
Cilazapril—Headache—Montelukast—chronic obstructive pulmonary disease	0.000211	0.00102	CcSEcCtD
Cilazapril—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000209	0.00101	CcSEcCtD
Cilazapril—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.001	CcSEcCtD
Cilazapril—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000208	0.001	CcSEcCtD
Cilazapril—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.000995	CcSEcCtD
Cilazapril—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000992	CcSEcCtD
Cilazapril—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.000988	CcSEcCtD
Cilazapril—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.000987	CcSEcCtD
Cilazapril—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.000986	CcSEcCtD
Cilazapril—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.000986	CcSEcCtD
Cilazapril—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.000985	CcSEcCtD
Cilazapril—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000204	0.000985	CcSEcCtD
Cilazapril—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.00098	CcSEcCtD
Cilazapril—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.000967	CcSEcCtD
Cilazapril—Nausea—Montelukast—chronic obstructive pulmonary disease	0.0002	0.000964	CcSEcCtD
Cilazapril—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.00095	CcSEcCtD
Cilazapril—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000935	CcSEcCtD
Cilazapril—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00093	CcSEcCtD
Cilazapril—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.000925	CcSEcCtD
Cilazapril—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.000898	CcSEcCtD
Cilazapril—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.000883	CcSEcCtD
Cilazapril—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.000876	CcSEcCtD
Cilazapril—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.000868	CcSEcCtD
Cilazapril—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000852	CcSEcCtD
Cilazapril—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000833	CcSEcCtD
Cilazapril—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000829	CcSEcCtD
Cilazapril—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00082	CcSEcCtD
Cilazapril—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.000812	CcSEcCtD
Cilazapril—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000811	CcSEcCtD
Cilazapril—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.000806	CcSEcCtD
Cilazapril—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.000768	CcSEcCtD
Cilazapril—Nateglinide—ALB—chronic obstructive pulmonary disease	0.000158	0.0196	CrCbGaD
Cilazapril—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000742	CcSEcCtD
Cilazapril—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.00074	CcSEcCtD
Cilazapril—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000739	CcSEcCtD
Cilazapril—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00073	CcSEcCtD
Cilazapril—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000721	CcSEcCtD
Cilazapril—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000718	CcSEcCtD
Cilazapril—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000717	CcSEcCtD
Cilazapril—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.000713	CcSEcCtD
Cilazapril—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000702	CcSEcCtD
Cilazapril—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00069	CcSEcCtD
Cilazapril—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00068	CcSEcCtD
Cilazapril—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00068	CcSEcCtD
Cilazapril—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000678	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000676	CcSEcCtD
Cilazapril—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000672	CcSEcCtD
Cilazapril—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000661	CcSEcCtD
Cilazapril—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000652	CcSEcCtD
Cilazapril—Shock—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000642	CcSEcCtD
Cilazapril—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000637	CcSEcCtD
Cilazapril—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000634	CcSEcCtD
Cilazapril—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000631	CcSEcCtD
Cilazapril—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000622	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000594	CcSEcCtD
Cilazapril—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000594	CcSEcCtD
Cilazapril—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00059	CcSEcCtD
Cilazapril—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000586	CcSEcCtD
Cilazapril—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000574	CcSEcCtD
Cilazapril—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000567	CcSEcCtD
Cilazapril—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000566	CcSEcCtD
Cilazapril—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000565	CcSEcCtD
Cilazapril—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000562	CcSEcCtD
Cilazapril—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000562	CcSEcCtD
Cilazapril—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000558	CcSEcCtD
Cilazapril—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000538	CcSEcCtD
Cilazapril—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000533	CcSEcCtD
Cilazapril—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000533	CcSEcCtD
Cilazapril—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000518	CcSEcCtD
Cilazapril—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000516	CcSEcCtD
Cilazapril—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.97e-05	0.000481	CcSEcCtD
Cilazapril—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.71e-05	0.000468	CcSEcCtD
Cilazapril—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.58e-05	0.000461	CcSEcCtD
Cilazapril—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.26e-05	0.000446	CcSEcCtD
Cilazapril—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.95e-05	0.000431	CcSEcCtD
Cilazapril—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.61e-05	0.000415	CcSEcCtD
Cilazapril—Rash—Prednisone—chronic obstructive pulmonary disease	8.53e-05	0.000411	CcSEcCtD
Cilazapril—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.53e-05	0.000411	CcSEcCtD
Cilazapril—Headache—Prednisone—chronic obstructive pulmonary disease	8.48e-05	0.000409	CcSEcCtD
Cilazapril—Nausea—Prednisone—chronic obstructive pulmonary disease	8.04e-05	0.000387	CcSEcCtD
